{"id":"NCT01939314","sponsor":"Indiana University","briefTitle":"Sphenopalatine Nerve Block for Headache Tx360","officialTitle":"A Prospective, Randomized, Double-Blind Study Comparing the Efficacy of Sphenopalatine Nerve Block by Localized Mucosal Application of an Anesthetic vs Placebo for the Emergency Department Management","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2013-12","completion":"2013-12","firstPosted":"2013-09-11","resultsPosted":"2015-07-27","lastUpdate":"2015-07-27"},"enrollment":93,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Headache","Migraine"],"interventions":[{"type":"DRUG","name":"Bupivacaine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":["Normal Saline"]}],"arms":[{"label":"Bupivacaine","type":"ACTIVE_COMPARATOR"},{"label":"Normal Saline","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to evaluate the efficacy of sphenopalatine nerve block utilizing the Tx360 (device) to deliver an anesthetic agent (bupivacaine) and to assess the duration of the analgesia.","primaryOutcome":{"measure":"Number of Participants Who Reported a 50% or Greater Reduction in Pain at 15 Minutes as Measured on the 100mm Visual Analog Scale","timeFrame":"15 minutes from dose","effectByArm":[{"arm":"Bupivacaine","deltaMin":48.8,"sd":null},{"arm":"Normal Saline","deltaMin":41.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":41},"commonTop":["Nasal Congestion","Minor Epistaxis","Sore Throat","Hoarseness","Nasal Dryness"]}}